Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Kono

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
BMJ Open|June 25, 2015
Effectiveness of community-based health services by nurse practitioners: protocol for a systematic review and meta-analysisMikiko Kanda, Erika Ota, Hiromi Fukuda, et al.
Clinical Journal of Gastroenterology|January 10, 2020
Simultaneous macroamylasemia and macrolipasemia in a patient with mucosa-associated lymphoid tissue lymphomaNobuhiko Ogasawara, Tsunao Imamura, Yoshiki Sato, et al.
Respiratory Investigation|March 1, 2020
The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patientsMiho Tanaka, Yoshihiro Hattori, Tatsuya Ishii, et al.
Biomedical Physics & Engineering Express|June 12, 2018
Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced UltrasoundKibo Nam, Maria Stanczak, Andrej Lyshchik, et al.
Radiologic Clinics of North America|October 10, 2017
Screening and Surveillance of Hepatocellular Carcinoma: An Introduction to Ultrasound Liver Imaging Reporting and Data SystemDavid T Fetzer, Shuchi K Rodgers, Alison C Harris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2007
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinomaYuko Kono, Olivier Lucidarme, Sang-Hee Choi, et al.
Cell Metabolism|July 6, 2022
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerDaniel Q Huang, Amit G Singal, Yuko Kono, et al.
Thoracic Cancer|December 28, 2022
TAPO in first-line osimertinib therapy and continuation of osimertinibChihiro Mimura, Kazumi Kaneshiro, Shodai Fujimoto, et al.
Ultrasonography (Seoul, Korea)|July 17, 2019
Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washoutHyun Kyung Yang, Peter N Burns, Hyun-Jung Jang, et al.
Pulmonary Pharmacology & Therapeutics|October 20, 2009
Sphingosine kinase 1 regulates mucin production via ERK phosphorylationYuko Kono, Teruaki Nishiuma, Taro Okada, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
BMJ Open|June 25, 2015
Effectiveness of community-based health services by nurse practitioners: protocol for a systematic review and meta-analysisMikiko Kanda, Erika Ota, Hiromi Fukuda, et al.
Clinical Journal of Gastroenterology|January 10, 2020
Simultaneous macroamylasemia and macrolipasemia in a patient with mucosa-associated lymphoid tissue lymphomaNobuhiko Ogasawara, Tsunao Imamura, Yoshiki Sato, et al.
Respiratory Investigation|March 1, 2020
The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patientsMiho Tanaka, Yoshihiro Hattori, Tatsuya Ishii, et al.
Biomedical Physics & Engineering Express|June 12, 2018
Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced UltrasoundKibo Nam, Maria Stanczak, Andrej Lyshchik, et al.
Radiologic Clinics of North America|October 10, 2017
Screening and Surveillance of Hepatocellular Carcinoma: An Introduction to Ultrasound Liver Imaging Reporting and Data SystemDavid T Fetzer, Shuchi K Rodgers, Alison C Harris, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2007
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinomaYuko Kono, Olivier Lucidarme, Sang-Hee Choi, et al.
Cell Metabolism|July 6, 2022
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerDaniel Q Huang, Amit G Singal, Yuko Kono, et al.
Thoracic Cancer|December 28, 2022
TAPO in first-line osimertinib therapy and continuation of osimertinibChihiro Mimura, Kazumi Kaneshiro, Shodai Fujimoto, et al.
Ultrasonography (Seoul, Korea)|July 17, 2019
Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washoutHyun Kyung Yang, Peter N Burns, Hyun-Jung Jang, et al.
Pulmonary Pharmacology & Therapeutics|October 20, 2009
Sphingosine kinase 1 regulates mucin production via ERK phosphorylationYuko Kono, Teruaki Nishiuma, Taro Okada, et al.
Pageof 11